207 related articles for article (PubMed ID: 34360976)
21. The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells.
Truitt L; Freywald T; DeCoteau J; Sharfe N; Freywald A
Cancer Res; 2010 Feb; 70(3):1141-53. PubMed ID: 20086179
[TBL] [Abstract][Full Text] [Related]
22. Erythropoietin-producing hepatocellular receptor B6 is highly expressed in non-functioning pituitary neuroendocrine tumors and its expression correlates with tumor size.
Rubinfeld H; Cohen ZR; Bendavid U; Fichman-Horn S; Levy-Barda A; David C; Melamed P; Shimon I
Mol Biol Rep; 2024 Feb; 51(1):297. PubMed ID: 38341842
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional silencing of EphB6 receptor tyrosine kinase in invasive breast carcinoma cells and detection of methylated promoter by methylation specific PCR.
Fox BP; Kandpal RP
Biochem Biophys Res Commun; 2006 Feb; 340(1):268-76. PubMed ID: 16364251
[TBL] [Abstract][Full Text] [Related]
24. The EphB6 receptor inhibits JNK activation in T lymphocytes and modulates T cell receptor-mediated responses.
Freywald A; Sharfe N; Rashotte C; Grunberger T; Roifman CM
J Biol Chem; 2003 Mar; 278(12):10150-6. PubMed ID: 12517763
[TBL] [Abstract][Full Text] [Related]
25. Eph receptor signalling: from catalytic to non-catalytic functions.
Liang LY; Patel O; Janes PW; Murphy JM; Lucet IS
Oncogene; 2019 Sep; 38(39):6567-6584. PubMed ID: 31406248
[TBL] [Abstract][Full Text] [Related]
26. Coupled regulation by the juxtamembrane and sterile α motif (SAM) linker is a hallmark of ephrin tyrosine kinase evolution.
Kwon A; John M; Ruan Z; Kannan N
J Biol Chem; 2018 Apr; 293(14):5102-5116. PubMed ID: 29432127
[TBL] [Abstract][Full Text] [Related]
27. A juxtamembrane autophosphorylation site in the Eph family receptor tyrosine kinase, Sek, mediates high affinity interaction with p59fyn.
Ellis C; Kasmi F; Ganju P; Walls E; Panayotou G; Reith AD
Oncogene; 1996 Apr; 12(8):1727-36. PubMed ID: 8622893
[TBL] [Abstract][Full Text] [Related]
28. The kinase defective EPHB6 receptor tyrosine kinase activates MAP kinase signaling in lung adenocarcinoma.
Yu J; Bulk E; Ji P; Hascher A; Koschmieder S; Berdel WE; Müller-Tidow C
Int J Oncol; 2009 Jul; 35(1):175-9. PubMed ID: 19513565
[TBL] [Abstract][Full Text] [Related]
29. Acute DSS colitis alters EphB6 receptor expression in neurons of the spinal dorsal horn.
King DE
Neurosci Lett; 2014 Jan; 559():105-10. PubMed ID: 24309292
[TBL] [Abstract][Full Text] [Related]
30. Mutations of the EPHB6 receptor tyrosine kinase induce a pro-metastatic phenotype in non-small cell lung cancer.
Bulk E; Yu J; Hascher A; Koschmieder S; Wiewrodt R; Krug U; Timmermann B; Marra A; Hillejan L; Wiebe K; Berdel WE; Schwab A; Müller-Tidow C
PLoS One; 2012; 7(12):e44591. PubMed ID: 23226491
[TBL] [Abstract][Full Text] [Related]
31. The intrinsically kinase-inactive EPHB6 receptor predisposes cancer cells to DR5-induced apoptosis by promoting mitochondrial fragmentation.
El Zawily AM; Toosi BM; Freywald T; Indukuri VV; Vizeacoumar FJ; Leary SC; Freywald A
Oncotarget; 2016 Nov; 7(47):77865-77877. PubMed ID: 27788485
[TBL] [Abstract][Full Text] [Related]
32. Tyrosine kinase-deficient EphB6 receptor-dependent alterations in proteomic profiles of invasive breast carcinoma cells as determined by difference gel electrophoresis.
Kandpal RP
Cancer Genomics Proteomics; 2010; 7(5):253-60. PubMed ID: 20952760
[TBL] [Abstract][Full Text] [Related]
33. The EphB6 receptor is overexpressed in pediatric T cell acute lymphoblastic leukemia and increases its sensitivity to doxorubicin treatment.
El Zawily A; McEwen E; Toosi B; Vizeacoumar FS; Freywald T; Vizeacoumar FJ; Freywald A
Sci Rep; 2017 Nov; 7(1):14767. PubMed ID: 29116180
[TBL] [Abstract][Full Text] [Related]
34. RTK SLAP down: the emerging role of Src-like adaptor protein as a key player in receptor tyrosine kinase signaling.
Wybenga-Groot LE; McGlade CJ
Cell Signal; 2015 Feb; 27(2):267-74. PubMed ID: 25446260
[TBL] [Abstract][Full Text] [Related]
35. Ephrin-B2 is a candidate ligand for the Eph receptor, EphB6.
Munthe E; Rian E; Holien T; Rasmussen A; Levy FO; Aasheim H
FEBS Lett; 2000 Jan; 466(1):169-74. PubMed ID: 10648835
[TBL] [Abstract][Full Text] [Related]
36. SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo.
Lerner EC; Smithgall TE
Nat Struct Biol; 2002 May; 9(5):365-9. PubMed ID: 11976726
[TBL] [Abstract][Full Text] [Related]
37. T-cell-specific expression of kinase-defective Eph-family receptor protein, EphB6 in normal as well as transformed hematopoietic cells.
Shimoyama M; Matsuoka H; Tamekane A; Ito M; Iwata N; Inoue R; Chihara K; Furuya A; Hanai N; Matsui T
Growth Factors; 2000; 18(1):63-78. PubMed ID: 10831073
[TBL] [Abstract][Full Text] [Related]
38. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
[TBL] [Abstract][Full Text] [Related]
39. Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells.
Holland SJ; Gale NW; Gish GD; Roth RA; Songyang Z; Cantley LC; Henkemeyer M; Yancopoulos GD; Pawson T
EMBO J; 1997 Jul; 16(13):3877-88. PubMed ID: 9233798
[TBL] [Abstract][Full Text] [Related]
40. Loss of EphB6 expression in metastatic melanoma.
Hafner C; Bataille F; Meyer S; Becker B; Roesch A; Landthaler M; Vogt T
Int J Oncol; 2003 Dec; 23(6):1553-9. PubMed ID: 14612926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
